Nuvation Bio Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Nuvation Bio Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-43.3×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 70% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-30.3×Operating cash was negative last year, while some debt falls due within a year.
Lower than 64% of Healthcare companies in United States.
Cash Cushion Ratio
+29%Cash, after subtracting all debt, equals 29% of its market value (net cash).
Higher than 68% of Healthcare companies in United States.
Tangible Assets Ratio
98%Of every $100 the company owns, $98 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 84% of Healthcare companies in United States.
Tangible Net Worth Ratio
96%Of every $100 of net worth, $96 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 84% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Nuvation Bio Inc. made a loss over the last year. Nuvation Bio Inc. owes $0.66 for every $1 it owns. Nuvation Bio Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossNuvation Bio Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
6.32The share price is 6.32 times Nuvation Bio Inc.'s book value per share, higher than 77% of Healthcare companies in United States.
Market cap
$1.6 BThe total market value of all of Nuvation Bio Inc.'s shares at today's price (share price × number of shares), larger than 70% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$254 MWhat Nuvation Bio Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.72Net worth divided by the number of shares. The share price of $4.57 is 6.3 times this, which is the P/B above.
Return on equity (ROE)
-47.8%Nuvation Bio Inc. lost 47.8% of its shareholders' money over the last year, higher than 50% of Healthcare companies in United States.
Owes vs Owns
0.66×Nuvation Bio Inc. owes $0.66 for every $1 it owns (moderate), higher than 69% of Healthcare companies in United States.
Dividend yield
NoneNuvation Bio Inc. does not currently pay a dividend.
Revenue growth
+699%Revenue rose 699% in the year to Dec 2025.
Profit growth
LossNuvation Bio Inc. made a loss in each of the last two years.
Profit margin
-325.3%Nuvation Bio Inc. lost $325 for every $100 of revenue.
Interest cover
Not coveredNuvation Bio Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashNuvation Bio Inc. held $472 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Nuvation Bio Inc.: $1.6 B ÷ $254 M (30 Jun 2026) = 6.3.
What is Nuvation Bio Inc.'s return on equity?
Nuvation Bio Inc. lost 47.8% of its shareholders' money over the last year, higher than 50% of Healthcare companies in United States.
How much does Nuvation Bio Inc. owe compared with what it owns?
Nuvation Bio Inc. owes $0.66 for every $1 it owns (moderate), higher than 69% of Healthcare companies in United States.
Does Nuvation Bio Inc. pay a dividend?
No. Nuvation Bio Inc. does not currently pay a dividend.
Is Nuvation Bio Inc.'s revenue growing?
Revenue rose 699% in the year to Dec 2025.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.